Iranian Journal of Medical Sciences

Document Type : Letter(s) to the Editor

Author

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

10.30476/ijms.2025.107413.4183

Abstract

I read with great interest the article by Safarpour and colleagues on the epidemiology of hepatitis D virus (HDV) and its associated factors in southern Iran. 

Highlights

Kamran Bagheri Lankarani (Google Scholar)

Keywords

  1. Safarpour AR, Shahedi A, Fattahi MR, Sadeghi E, Akbarzadeh M, Ahmadi L, et al. Epidemiology of Hepatitis D Virus and Associated Factors in Patients Referred to Level Three Hepatitis Clinic, Fars Province, Southern Iran. Iran J Med Sci. 2025;50:220-8. doi: 10.30476/ijms.2024.101949.3469. PubMed PMID: 40255222; PubMed Central PMCID: PMCPMC12008655.
  2. Sausen DG, Shechter O, Bietsch W, Shi Z, Miller SM, Gallo ES, et al. Hepatitis B and Hepatitis D Viruses: A Comprehensive Update with an Immunological Focus. Int J Mol Sci. 2022;23. doi: 10.3390/ijms232415973. PubMed PMID: 36555623; PubMed Central PMCID: PMCPMC9781095.
  3. European Association for the Study of the L. EASL Clinical Practice Guidelines on hepatitis delta virus. J Hepatol. 2023;79:433-60. doi: 10.1016/j.jhep.2023.05.001. PubMed PMID: 37364791.
  4. Motamedifar MP, Taheri MM, Lankarani KBM, Gholami MB, Lari MAM, Faramarzi HM, et al. The Prevalence and Risk Factors of Hepatitis Delta Virus in HIV/HBV Co-Infected Patients in Shiraz, Iran, 2012. Iran J Med Sci. 2015;40:448-53. PubMed PMID: 26379352; PubMed Central PMCID: PMCPMC4567605.